SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers:
SEC Accession No. 0001601830-23-000036
Filing Date
2023-05-30
Accepted
2023-05-30 17:12:35
Documents
10
Effectiveness Date
2023-05-30

Document Format Files

Seq Description Document Type Size
1 S-3ASR valences-3.htm S-3ASR 386324
2 EX-FILING FEES exhibit107-feetable.htm EX-FILING FEES 37564
3 EX-4.2 exhibit42-valencexexchange.htm EX-4.2 213399
4 EX-4.3 exhibit43-valencexregistra.htm EX-4.3 62647
5 EX-5.1 ex51wsgropinionvalence.htm EX-5.1 23890
6 EX-23.1 ex231eys-3consentvalence.htm EX-23.1 2722
7 image_0.jpg GRAPHIC 74541
8 image_11.jpg GRAPHIC 87
9 image_3.jpg GRAPHIC 15025
10 image_4.jpg GRAPHIC 13211
  Complete submission text file 0001601830-23-000036.txt   869623
Mailing Address 41S RIO GRANDE STREET SALT LAKE CITY UT 84101
Business Address 41S RIO GRANDE STREET SALT LAKE CITY UT 84101 (385) 269-0203
RECURSION PHARMACEUTICALS, INC. (Filer) CIK: 0001601830 (see all company filings)

IRS No.: 464099738 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3ASR | Act: 33 | File No.: 333-272281 | Film No.: 23977647
SIC: 2836 Biological Products, (No Diagnostic Substances)